Allogene Therapeutics Inc (ALLO)
R&D Expenses
$122.52M
TTM · Period ending: · USD
ALLO R&D Expenses
Latest reported$122.52Mperiod ending
Latest reported$122.52Mperiod ending
ALLO R&D Expenses ($0.00 → $122.52M)
Annual R&D Expenses
High-resolution chart · PNG
ALLO r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 150,152,000 | |
| 192,299,000 | |
| 242,914,000 | |
| 256,387,000 | |
| 220,176,000 | |
| 192,987,000 | |
| 144,535,000 | |
| 151,860,000 | |
| 0 |